Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenge Zhu

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Science Advances|August 6, 2025
AND-1 is a critical regulator of R-loop dynamics and a target to overcome endocrine resistanceZhuqing Li, Yihan Peng, Huai-Chin Chiang, et al.
Cancer Management and Research|May 8, 2018
Association of two <i>FOXP3</i> polymorphisms with breast cancer susceptibility in Chinese Han womenTian Tian, Meng Wang, Yi Zheng, et al.
Clinical and Experimental Medicine|November 16, 2016
Association of genetic polymorphisms in MIF with breast cancer risk in Chinese womenShuai Lin, Meng Wang, Xinghan Liu, et al.
The EMBO Journal|April 30, 2020
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sitesZhaohua Hu, Shaojie Mi, Ting Zhao, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysisTian Tian, Meng Wang, Shuai Lin, et al.
Oncotarget|December 7, 2017
Genetic polymorphisms in caveolin-1 associate with breast cancer risk in Chinese Han populationMeng Wang, Tian Tian, Xiaobin Ma, et al.
Molecular Therapy. Nucleic Acids|October 28, 2018
Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast CancerTian Tian, Meng Wang, Yuyao Zhu, et al.
Oncotarget|November 9, 2017
IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control studyZhi-Jun Dai, Xing-Han Liu, Meng Wang, et al.
Oncogene|December 7, 2018
DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)Chi-Wei Chen, Yongming Li, Shuya Hu, et al.
Research Square|October 27, 2023
<i>O</i>-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerWenge Zhu, Y I Zhang, Shuyan Zhou, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Science Advances|August 6, 2025
AND-1 is a critical regulator of R-loop dynamics and a target to overcome endocrine resistanceZhuqing Li, Yihan Peng, Huai-Chin Chiang, et al.
Cancer Management and Research|May 8, 2018
Association of two <i>FOXP3</i> polymorphisms with breast cancer susceptibility in Chinese Han womenTian Tian, Meng Wang, Yi Zheng, et al.
Clinical and Experimental Medicine|November 16, 2016
Association of genetic polymorphisms in MIF with breast cancer risk in Chinese womenShuai Lin, Meng Wang, Xinghan Liu, et al.
The EMBO Journal|April 30, 2020
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sitesZhaohua Hu, Shaojie Mi, Ting Zhao, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysisTian Tian, Meng Wang, Shuai Lin, et al.
Oncotarget|December 7, 2017
Genetic polymorphisms in caveolin-1 associate with breast cancer risk in Chinese Han populationMeng Wang, Tian Tian, Xiaobin Ma, et al.
Molecular Therapy. Nucleic Acids|October 28, 2018
Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast CancerTian Tian, Meng Wang, Yuyao Zhu, et al.
Oncotarget|November 9, 2017
IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control studyZhi-Jun Dai, Xing-Han Liu, Meng Wang, et al.
Oncogene|December 7, 2018
DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)Chi-Wei Chen, Yongming Li, Shuya Hu, et al.
Research Square|October 27, 2023
<i>O</i>-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerWenge Zhu, Y I Zhang, Shuyan Zhou, et al.
Pageof 6